menu
    • menu

    Company profile for Fulgent Pharma

    NEW Drugs in Dev: 3
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Fulgent Pharma began as Fulgent Therapeutics in Temple City, California, in June 2011. As the company progressed into the sphere of personalized medicine, it also started delving into clinical genetic testing - a natural complement. In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives. Today, Fulgent Pharma is fully f...
    Fulgent Pharma began as Fulgent Therapeutics in Temple City, California, in June 2011. As the company progressed into the sphere of personalized medicine, it also started delving into clinical genetic testing - a natural complement. In 2016, Fulgent Therapeutics split into two separate entities - Fulgent Pharma and Fulgent Genetics - in order to better pursue their independent objectives. Today, Fulgent Pharma is fully focused on perfecting drug candidates for treating a broad range of cancers. Our partners in this endeavor include the University of Southern California, Moffitt Cancer Center, and ANP Technologies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Fulgent PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4978 Santa Anita Ave. Temple City, CA 91780 (US)
    Telephone
    Telephone
    +1 626 434 8896
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.fulgentpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fulgent to Report Q4, Full-Year 2025 Results on Feb. 27
    Fulgent to Report Q4, Full-Year 2025 Results on Feb. 27

    12 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260212618262/en/Fulgent-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-Friday-February-27-2026

    BUSINESSWIRE
    12 Feb 2026
    Share Share
    Fulgent Reports Third Quarter 2025 Financial Results
    Fulgent Reports Third Quarter 2025 Financial Results

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107899130/en/Fulgent-Reports-Third-Quarter-2025-Financial-Results

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    Fulgent To Participate In Upcoming Conferences
    Fulgent To Participate In Upcoming Conferences

    07 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251107415109/en/Fulgent-to-Participate-in-Upcoming-Conferences

    BUSINESSWIRE
    07 Nov 2025
    Share Share
    Fulgent Reports Second Quarter 2025 Financial Results
    Fulgent Reports Second Quarter 2025 Financial Results

    01 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250801731804/en/Fulgent-Reports-Second-Quarter-2025-Financial-Results

    BUSINESSWIRE
    01 Aug 2025
    Share Share
    Fulgent Genetics Gets EU CE Mark for Genomic Tools
    Fulgent Genetics Gets EU CE Mark for Genomic Tools

    17 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250717236823/en/Fulgent-Genetics-Receives-EU-CE-Mark-for-FulgentExome-FulgentPLM

    BUSINESSWIRE
    17 Jul 2025
    Share Share
    Fulgent to Announce Q2 2025 Financial Results on August 1
    Fulgent to Announce Q2 2025 Financial Results on August 1

    10 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250710790581/en/Fulgent-to-Announce-Second-Quarter-2025-Financial-Results-on-Friday-August-1-2025

    BUSINESSWIRE
    10 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search